Japan has approved Eisai and Biogen’s Leqembi treatment for Alzheimer’s disease
![](https://4gi.tv/wp-content/uploads/2023/09/2709-ws-he-1024x576.jpg)
Japanese company Eisai has announced that its Alzheimer’s disease treatment developed with Biogen, Leqembi, has been approved by the country’s Ministry of Health, making it the second country after the United States to clear its use. It can now be used in Japan to treat slowing the progression of mild cognitive impairment and mild dementia caused by Alzheimer’s disease.
POPULAR POSTS
![](https://4gi.tv/wp-content/uploads/2024/07/2607-02.png)
‘The Kardashians’ renewed by Hulu for 20 more episodes
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env2.jpg)
Death toll from landslides in Ethiopia could rise to 500
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env1.jpg)
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env.jpg)
The Canadian wildfire has made its way to Jasper
July 26, 2024
LIVE STREAM